MktsMarkets

Pyxis Oncology, Inc.
NASDAQ: PYXSKey statistics
PYXS News
Stories mentioning PYXS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,820 | |||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 19,983 | 21,711 | 17,808 | 17,133 | 17,044 | 14,024 | 17,741 | 13,953 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 24,360 | 22,914 | ||||||
| Operating Income (Loss) | (24,360) | (18,295) | (23,461) | (19,750) | (22,914) | (40,069) | (23,754) | (20,032) |
| Interest Income | 218.00 | 225.00 | 242.00 | 99.00 | 84.00 | 87.00 | 194.00 | 387.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (22,003) | (18,071) | (21,203) | (17,301) | ||||
| Tax Provision | 283.00 | |||||||
| Net Income (Loss) | (23,272) | (18,106) | (22,003) | (18,354) | (21,158) | (35,571) | (21,203) | (17,301) |
| Earnings Per Share (Basic) | (0.37) | (0.29) | (0.35) | (0.30) | (0.35) | (0.61) | (0.35) | (0.29) |
| Earnings Per Share (Diluted) | (0.37) | (0.29) | (0.35) | (0.30) | (0.35) | (0.61) | (0.35) | (0.29) |
| Weighted Average Shares Outstanding (Basic) | 63,470 | 62,143 | 62,557 | 61,919 | 61,049 | 58,446 | 60,715 | 60,496 |
| Weighted Average Shares Outstanding (Diluted) | 63,470 | 62,143 | 62,557 | 61,919 | 61,049 | 58,446 | 60,715 | 60,496 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PYXS
Pyxis Oncology, Inc. (NASDAQ: PYXS) is a stock listed on the Nasdaq Stock Market under the ticker symbol PYXS. It last traded at $1.44 (Nov 18, 2026, 1:29 PM ET), unchanged on the day. That gives Pyxis Oncology a market capitalisation of $172.2M.
Over the past 52 weeks PYXS has traded between $1.03 and $5.55.
For the quarter ended Mar 31, 2026 it reported a net loss of $23.3M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$23.3M | — |
| Dec 31, 2025 | — | -$18.1M | — |
| Sep 30, 2025 | — | -$22.0M | — |
| Jun 30, 2025 | $2.8M | -$18.4M | -650.9% |
From Pyxis Oncology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…